SNY logo

Sanofi (SNY) Company Overview

Profile

Full Name:

Sanofi

Sector:

Healthcare

Industry:

Drug Manufacturers - General

Country:

France

IPO:

July 1, 2002

Indexes:

Not included

Website:

http://www.sanofi.com

Description:

Sanofi is an international pharmaceutical company based in Paris, France. The company was founded in 1973. Initially, it was one of the divisions of the Elf Aquitane company (petrochemical industry). In 1979, it was formed as a separate full-fledged pharmaceutical company. Sanofi produces vaccines, general medicines, products for the treatment of diabetes and cardiovascular diseases, and veterinary products. The company also has divisions that focus on innovative biotechnologies and research in the healthcare field (oncology, immunology, multiple sclerosis, rare diseases). The R&D (research and development) segment is well developed - with around 100 active development projects; around 40 projects are in the final stages or approved.

Key Details

Price

$59.01

Market Cap

$147.95 B(Mega cap)

Last Dividend

$2.04

TTM Dividend Yield

3.45%

Annual Revenue

$47.93 B(+6.39% YoY)

Annual EPS

$2.40(+3.00% YoY)

PE Ratio

23.62

Annual ROE

7.37%

Annual Debt To Equity

0.21

Beta

0.07

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Jan 30, 2025

Recent annual earnings:

Jan 30, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

May 9, 2024
Splits

Next split:

N/A

Recent split:

Sep 30, 2013

Analyst ratings

Recent major analysts updates

Jul 26, 24 Argus Research
Buy
Jan 23, 24 Morgan Stanley
Equal-Weight
Mar 27, 23 Argus Research
Buy
Aug 12, 22 Deutsche Bank
Hold
Sep 27, 21 SVB Leerink
Outperform
Jan 15, 21 Deutsche Bank
Sell
Mar 11, 20 Goldman Sachs
Buy
Feb 19, 20 Argus Research
Buy
Feb 11, 20 SVB Leerink
Market Perform
Jan 6, 20 JP Morgan
Overweight

Screeners with SNY included

Growing Shares Outstanding
Stocks with high RSI
Best performing stocks last 5 years
Stocks above SMA 50
Healthcare sector
Mega cap stocks
Companies with growing dividends
All stocks
Best performing stocks last 15 years
Stocks with low beta

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$59.01
SNY price is $59.01

Price All-time High

$59.01
SNY price is currently at an all-time high

Price Analysts Target

-
SNY price consensus analysts' forecast is unknown

Price Most Recent Change

+1.92%
SNY price was up +1.92% on Mar 6, 2025

Price YTD Change

+24.51%
SNY price is up +24.51% since January 1st

Price 3-Year Change

+21.72%
SNY price is up +21.72% over the past 3 years

Market cap

Market Cap

$147.95 B
SNY market capitalization is $147.95 billion

Market Cap 3-Year Change

+22.2%
SNY market capitalization is up +22.2% over the past 3 years

Market Cap All-time High

$151.34 B
SNY market capitalization is currently -2.24% below its historical high of $151.34 billion

Market Cap Sector Rank

98.77%
SNY market capitalization is higher than 98.77% of companies in Healthcare sector

Technical

Beta

0.07
SNY beta is 0.07

200-day SMA

$51.89
SNY price is currently +13.73% above its 200-day simple moving average

14-day RSI

75.57
SNY 14-day relative strength index is 75.57

30-day Relative Volume

1.46
SNY 30-day relative volume is 1.46

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$2.04
SNY last dividend was $2.04 per share, with an ex-dividend date of May 9, 2024

Next Dividend

-
SNY next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$2.04
SNY annual dividend per share is $2.04

Annual Dividend Per Share Sector Rank

72.29%
SNY annual dividend per share is higher than 72.29% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+7.23%
SNY annual dividend per share is up +7.23% year-on-year

Annual Dividend Per Share 3-Year Change

+5.63%
SNY annual dividend per share is up +5.63% over the past 3 years

Dividend yield

Annual Dividend Yield

3.45%
SNY annual dividend yield is 3.45%

Annual Dividend Yield Sector Rank

76.83%
SNY annual dividend yield is higher than 76.83% of companies in Healthcare sector

Other

Annual Payout Ratio

84.60%
SNY annual payout ratio is 84.60%

Annual Dividends Paid

$5.09 B
SNY annual dividends paid is $5.09 billion

Annual FCF

$6.37 B
SNY annual free cash flow is $6.37 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$47.93 B
SNY annual revenue is $47.93 billion

Annual Revenue Analysts Estimate

$46.52 B
SNY annual revenue is currently +3.03% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+6.39%
SNY annual revenue is up +6.39% year-on-year

Annual Revenue Sector Rank

98.02%
SNY annual revenue is higher than 98.02% of companies in Healthcare sector

Profit

Annual Gross Profit

$33.64 B
SNY annual gross profit is $33.64 billion

Annual Gross Margin

70.18%
SNY annual gross profit margin is 70.18%

Annual Operating Profit

$10.24 B
SNY annual operating income is $10.24 billion

Annual Operating Margin

21.37%
SNY annual operating profit margin is 21.37%

Annual Net Income

$6.02 B
SNY annual net profit is $6.02 billion

Annual Net Margin

12.97%
SNY annual net profit margin is 12.97%

EPS

Annual EPS

$2.40
SNY annual earnings per share is $2.40

Annual EPS Analysts Estimate

$5.15
SNY annual earnings per share is currently -53.44% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+3%
SNY annual earnings per share is up +3% year-on-year

Annual EPS Sector Rank

92.75%
SNY annual earnings per share is higher than 92.75% of companies in Healthcare sector

ROA & ROE

Annual ROA

4.33%
SNY annual return on assets is 4.33%

Annual ROE

7.37%
SNY annual return on equity is 7.37%

EBIT & EBITDA

Annual EBIT

$8.67 B
SNY annual earnings before interest & taxes is $8.67 billion

Annual EBITDA

$10.56 B
SNY annual EBITDA is $10.56 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

23.62
SNY price to earnings ratio is 23.62

PE Ratio Sector Rank

44.67%
SNY price to earnings ratio is higher than 44.67% of companies in Healthcare sector

PB Ratio

PB Ratio

1.83
SNY price to book ratio is 1.83

PB Ratio Sector Rank

57.59%
SNY price to book ratio is higher than 57.59% of companies in Healthcare sector

PS Ratio

PS Ratio

3.08
SNY price to sales ratio is 3.08

PS Ratio Sector Rank

49.48%
SNY price to sales ratio is higher than 49.48% of companies in Healthcare sector

Enterprise value

Enterprise Value

$158.84 B
SNY enterprise value is $158.84 billion

Enterprise Value Sector Rank

98.66%
SNY enterprise value is higher than 98.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.36
SNY EV/EBITDA is 14.36

EV/EBITDA Sector Rank

86.74%
SNY EV/EBITDA is higher than 86.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.46
SNY annual current ratio is 1.46

Annual Quick Ratio

0.74
SNY annual quick ratio is 0.74

Leverage

Annual Debt To Equity

0.21
SNY annual debt to equity ratio is 0.21

Annual Interest Coverage Ratio

10.69
SNY annual interest coverage ratio is 10.69

Risk & Stability

Piotroski F-Score

-
SNY piotroski f-score value is unknown

Altman Z-Score

-
SNY altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$138.19 B
SNY annual total assets is $138.19 billion

Annual Non Current Assets

$94.06 B
SNY annual long term assets is $94.06 billion

Annual Current Assets

$44.31 B
SNY annual total current assets is $44.31 billion

Annual Cash & Cash Equivalents

$7.74 B
SNY annual cash & cash equivalents is $7.74 billion

Equity

Annual Book Value

$80.84 B
SNY annual book value is $80.84 billion

Annual Working Capital

$13.97 B
SNY annual working capital is $13.97 billion

Liabilities

Annual Total Liabilities

$57.17 B
SNY annual total liabilities is $57.17 billion

Annual Total Long Term Liabilities

$26.82 B
SNY annual total long term liabilities is $26.82 billion

Annual Current Liabilities

$30.34 B
SNY annual total current liabilities is $30.34 billion

Annual Accounts Payable

$22.68 B
SNY annual accounts payable is $22.68 billion

Debt

Annual Total Debt

$18.63 B
SNY annual total debt is $18.63 billion

Annual Total Debt 1-Year Change

-8.5%
SNY annual total debt is down -8.5% year-on-year

Annual Long Term Debt

$13.98 B
SNY annual long term debt is $13.98 billion

Annual Short Term Debt

$4.65 B
SNY annual short term debt is $4.65 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$37.69 B
SNY annual total expenses is $37.69 billion

Annual Operating Expenses

$23.40 B
SNY annual total operating expenses is $23.40 billion

Annual Cost Of Goods Sold

$14.29 B
SNY annual cost of goods sold is $14.29 billion

Annual SGA

$9.94 B
SNY annual SGA is $9.94 billion

Annual D&A

$3.88 B
SNY annual depreciation & amortization is $3.88 billion

Annual Interest Expense

$810.68 M
SNY annual interest expense is $810.68 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$9.83 B
SNY annual cash flow from operations is $9.83 billion

Annual CFO 1-Year Change

-11.5%
SNY annual cash flow from operations is down -11.5% year-on-year

Annual CFI

-$4.77 B
SNY annual cash flow from investing activities is -$4.77 billion

Annual CFI 1-Year Change

+28.94%
SNY annual cash flow from investing activities is up +28.94% year-on-year

Annual CFF

-$6.24 B
SNY annual cash flow from financing activities is -$6.24 billion

Annual CFF 1-Year Change

+28.44%
SNY annual cash flow from financing activities is up +28.44% year-on-year

Free CashFlow

Annual FCF

$6.37 B
SNY annual free cash flow is $6.37 billion

Annual FCF 1-Year Change

-19.96%
SNY annual free cash flow is down -19.96% year-on-year

CAPEX

Annual CAPEX

$3.46 B
SNY annual capital expenditures is $3.46 billion

Annual CAPEX 1-Year Change

+9.92%
SNY annual capital expenditures is up +9.92% year-on-year

Institutional Ownership

Similar stocks

PFE logo
Pfizer (PFE)
DHR logo
Danaher (DHR)
GILD logo
Gilead Sciences (GILD)
SYK logo
Stryker (SYK)
BSX logo
Boston Scientific (BSX)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
AMGN logo
Amgen (AMGN)
BMY logo
Bristol-Myers Squibb (BMY)
MDT logo
Medtronic (MDT)

FAQ

  • What is the ticker symbol for Sanofi?
  • Does Sanofi pay dividends?
  • What sector is Sanofi in?
  • What industry is Sanofi in?
  • What country is Sanofi based in?
  • When did Sanofi go public?
  • Is Sanofi in the S&P 500?
  • Is Sanofi in the NASDAQ 100?
  • Is Sanofi in the Dow Jones?
  • When was Sanofi's last earnings report?
  • When does Sanofi report earnings?

What is the ticker symbol for Sanofi?

The ticker symbol for Sanofi is NASDAQ:SNY

Does Sanofi pay dividends?

Yes, Sanofi pays dividends. The last payment was $2.04, with an ex-dividend date on May 9, 2024

What sector is Sanofi in?

Sanofi is in the Healthcare sector

What industry is Sanofi in?

Sanofi is in the Drug Manufacturers - General industry

What country is Sanofi based in?

Sanofi is headquartered in France

When did Sanofi go public?

Sanofi's initial public offering (IPO) was on July 1, 2002

Is Sanofi in the S&P 500?

No, Sanofi is not included in the S&P 500 index

Is Sanofi in the NASDAQ 100?

No, Sanofi is not included in the NASDAQ 100 index

Is Sanofi in the Dow Jones?

No, Sanofi is not included in the Dow Jones index

When was Sanofi's last earnings report?

Sanofi's most recent earnings report was on Jan 30, 2025

When does Sanofi report earnings?

The next expected earnings date for Sanofi is Apr 24, 2025